Neurochemical characterization of canine alpha-L-iduronidase deficiency disease (model of human mucopolysaccharidosis I).
This report presents the neurochemical findings on the first dog to die with deficiency of alpha-L-iduronidase (mucopolysaccharide alpha-L-iduronohydrolase; EC 3.2.1.76). The principal findings were (a) markedly increased glycosaminoglycan content in all neural tissues examined (from threefold in sciatic nerve to 15-fold in brainstem), (b) a modest increase in levels of gangliosides GM2, GM3, and GD3, particularly in gray matter, (c) excessive accumulation of glycosaminoglycans in the CSF, (d) the increased glycosaminoglycans were dermatan sulfate and heparan sulfate, and (e) the molecular weights of the liver glycosaminoglycans were shifted toward smaller sizes, indicating partial degradation. The canine disorder thus resembles mucopolysaccharidosis I in all aspects.
D000818:Animals; D001923:Brain Chemistry; D001933:Brain Stem / Q000032:analysis; D003871:Dermatan Sulfate / Q000032:analysis; D004195:Disease Models, Animal; D004283:Dog Diseases / Q000503:physiopathology*; D004285:Dogs; D004588:Electrophoresis, Cellulose Acetate; D005260:Female; D005732:Gangliosides / Q000032:analysis; D006025:Glycosaminoglycans / Q000032:analysis; D006026:Glycoside Hydrolases / Q000172:deficiency*; D006497:Heparan Sulfate / Q000032:analysis; D007068:Iduronidase / Q000172:deficiency*; D008970:Molecular Weight; D009083:Mucopolysaccharidoses / Q000503:physiopathology*; D012584:Sciatic Nerve / Q000032:analysis
D003871:Dermatan Sulfate; D005732:Gangliosides; D006025:Glycosaminoglycans; D006026:Glycoside Hydrolases; D006497:Heparan Sulfate; D007068:Iduronidase